Predictive Technology Group Inc (PRED)

[speedo94947]

Great Potential mentioned from Article: Predictive Technologies: (OTCMKTS: PRED) Develops gene based diagnostics and companion therapeutics in the disease indications of Endometriosis, Scoliosis, and Degenerative Disc Disease, and regenerative human cell. It recently launched its Assurance AB which is a COVID-19 LgM/lgG rapid antibody test. This test is manufactured by Jiangsu Dablood Pharmaceuticals Co. Ltd. which distributed 38 million tests during the beginning of the outbreak. Current production capacity is 1.5 million units daily. The cores technology of the company is the burgeoning infertility business but they are poised to be the largest supplier in of antibody test kits. The company has about $5.0 million in current assets and a market cap of $248 million and seem well capitalized to scale up its testing business and should be the primary beneficiary of the back to work initiative which could be worth hundreds of millions in revenue this year.